Emergent Biosolutions Inc. Net Profit Margin

Net Profit Margin of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Profit Margin growth rates and interactive chart. The net profit margin is equal to how much net income or profit is generated as a percentage of revenue. Net profit margin is the ratio of net profits (or net income) to revenues for a company. Net profit margin is typically expressed as a percentage. The net profit margin illustrates how much of each dollar in revenue collected by a company translates into profit.

Highlights and Quick Summary

  • Net Profit Margin for the quarter ending June 30, 2023 was -77.33% (a -30.23% decrease compared to previous quarter)
  • Year-over-year quarterly Net Profit Margin increased by 145.18%
  • Annual Net Profit Margin for 2022 was -19.97% (a -255.05% decrease from previous year)
  • Annual Net Profit Margin for 2021 was 12.88% (a -34.35% decrease from previous year)
  • Annual Net Profit Margin for 2020 was 19.62% (a 297.97% increase from previous year)
  • Twelve month Net Profit Margin ending June 30, 2023 was -56.63% (a 37.45% increase compared to previous quarter)
  • Twelve month trailing Net Profit Margin decreased by -1699.72% year-over-year
Trailing Net Profit Margin for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
-56.63% -41.2% -19.97% 3.54%
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Profit Margin of Emergent Biosolutions Inc.

Most recent Net Profit Marginof EBS including historical data for past 10 years.

Interactive Chart of Net Profit Margin of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Net Profit Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -77.33% -110.84% – – –
2022 -26.61% -31.54% -23.24% -1.2% -19.97%
2021 26.18% -9.94% 1.16% 20.32% 12.88%
2020 31.8% 10.25% 23.49% -6.49% 19.62%
2019 12.99% 13.86% -3.91% -13.64% 4.93%
2018 -1.26% 12.04% 22.75% -4.16% 8.01%
2017 17.51% 22.45% 4.58% 8.97% 14.73%
2016 24.67% 14.93% -12.0% 3.88% 10.6%
2015 23.62% 23.33% 11.18% -33.82% 12.85%
2014 29.44% 15.83% 4.56% -37.55% 9.08%
2013 15.52% 15.14% 12.72% -18.71% 9.96%
2012 17.02% 9.94% – – 8.35%

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com